Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 2005, p. 1909-1914, Vol. 71, No. 4
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.4.1909-1914.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Sarah E. Askew,
and
David J. Leak*
Department of Biological Sciences, Imperial College London, London, United Kingdom
Received 23 July 2004/ Accepted 25 October 2004
|
|
|---|
|
|
|---|
Alkene monooxygenases have interesting prospects as biocatalysts for asymmetric synthesis (15). Although they belong to the same family of binuclear nonheme iron monooxygenases as soluble methane monooxygenase (sMMO) (14), they are able to discriminate between nonactivated C-H bonds and double bonds, specifically epoxidizing the latter, often with high enantiomeric excess (20). This discrimination appears to be a fundamental part of the catalytic mechanism, but stereoselectivity is probably a reflection of substrate binding. Therefore, it should be possible to modify stereoselectivity through protein engineering without a loss of reaction specificity, which is not likely to be the case with alkane or methane monooxygenases, for which epoxidation is a fortuitous consequence of the catalytic cycle and competing reactions such as allylic hydroxylation can also occur. However, nonheme iron monooxygenases are relatively complex, placing a considerable synthetic burden on the host cells, and simpler systems would be advantageous. The enzymes from X. autotrophicus Py2 and Rhodococcus corallinus are the most thoroughly characterized alkene monooxygenases. The former (XAMO) is a four-component system comprised of (i) an NADH oxidoreductase containing a noncovalently bound FAD molecule and a [2Fe-2S] cluster, (ii) a Rieske-type ferredoxin, (iii) a hexameric oxygenase (
2ß2
2) containing the binuclear iron active site, and (iv) a small coupling protein which is essential for activity (26). It has a high degree of sequence similarity to aromatic monooxygenases, including toluene 2-, 3-, and 4-monooxygenases (T2/3/4MO) and benzene monooxygenase, and also to isoprene monooxygenase, suggesting that these form a homologous group (35).
The alkene monooxygenase from R. corallinus B-276 (AMO) is a simpler, three-component system encoded by the four-gene operon amoABCD (23). It lacks the ferredoxin and the oxygenase
subunit (the oxygenase is an
2ß2 tetramer [18]), and the gene order differs from that in X. autotrophicus Py2. However, spectroscopic studies and important elements of structure and sequence conservation revealed that the
subunit contains a typical binuclear nonheme iron binding site (8).
The monooxygenase from Mycobacterium sp. strain M156 (PMO) has been more difficult to purify. However, a partial purification (32) indicated that it did not contain a ferredoxin component, suggesting that it is similar to the simpler three-component enzyme from R. corallinus B-276, and we have used this information as a starting point for the cloning, sequencing, and expression of the mycobacterial enzyme. Although the high levels of expression necessary for use as a recombinant biocatalyst have yet to be achieved, expression was sufficient to allow confirmation that by targeting appropriate residues, the stereoselectivity of alkene monooxygenases can be modified without losing reaction specificity.
|
|
|---|
M15 Tn10 (Tetr)]} was purchased from Stratagene. E. coli DH5
[supE44
lacY169 (
80 lacZ
M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1] and E. coli DH10B (F mcrA
[mrr hsdRMS mcrBC]
80d lacZ
M15
lacX74 deoR recA1 endA1 araD139
[ara leu]7697 galU galK l rpsL nupG) were obtained from GIBCO BRL. The E. coli cloning vector pBluescript II was purchased from Stratagene, and pSP72 (Ampr; contains oriE and a multiple cloning site) was purchased from Promega. The E. coli-mycobacterial shuttle vector pNBV1 (Hygr; contains oriE, oriM, and a multiple cloning site; suitable for blue-white colony screening) was obtained from W. R. Bishai (11), and pUS1872 (Kanr; contains oriM) was obtained from J. MacFadden (unpublished data).
Materials.
Hygromycin was obtained as a sterile stock solution (50 mg ml1) from Roche Diagnostics Ltd. All other chemicals were from Sigma-Aldrich and were analytical grade. Restriction enzymes and DNA-modifying enzymes (calf intestinal alkaline phosphatase and DNA ligase) were purchased from New England Biolabs and Roche Diagnostics Ltd., respectively. High-purity plasmid DNAs were purified from E. coli clones by the use of QIAprep Spin miniprep kits (QIAGEN), while DNAs were recovered from agarose gels by use of a DNA Wizard clean-up kit from Promega or a QIAQuick gel extraction kit from QIAGEN. Chemically competent E. coli DH5
, used for routine subcloning, was either purchased from Invitrogen or prepared as described by Sambrook et al. (24). E. coli DH10B which had been rendered electrocompetent (24) was used for mycobacterium library constructions. DNA primers were ordered from MWG-Biotech, and DNA sequencing was done by use of a BigDye Terminator cycle sequencing kit (Perkin-Elmer) with AmpliTaq FS DNA polymerase and analyzed on an ABI 377 automated sequencer (Applied Biosystems).
Southern blot analysis.
Chromosomal DNA from Mycobacterium sp. strain M156 was extracted as described by Pitcher et al. (19), and Southern blots were done according to the method of Sambrook et al. (24). Probe labeling and membrane hybridizations were performed according to the instructions in an ECL random-prime labeling and detection kit (Amersham). After overnight probe hybridization, Hybond N+ membranes containing chromosomal DNA were washed twice in 1x SSC (0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate (SDS) for 15 min at 60°C. Membranes containing plasmid DNA after the lysis of colonies were treated as described by Sambrook et al. (24), and posthybridization washes were done with 1x SSC-0.1% SDS and 0.2x SSC-0.1% SDS for 15 min each at 60°C.
Sequence analysis.
Open reading frame (ORF) searches were done on the Frameplot server (http://www.nih.go.jp/
jun/cgi-bin/frameplot.pl). Codon usage tables were created at http://www.kazusa.or.jp/codon/countcodon.html and compared (M. Furhmann, L. Ferbitz, A. Hausherr, and T. Schodl, unpublished data) at http://gcua.schoedl.de/. BLAST searches were performed at the National Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/BLAST) by use of the BLOSUM62 matrix, with a gap open penalty of 11 and a gap extension penalty of 1. Amino acid identities were calculated with the ALIGN program at http://www.infobiogen.fr/services/analyseq/cgi-bin/alignp_in.pl by use of the BLOSUM 50 matrix. Multiple alignments were done with CLUSTAL-X, version 1.8 (31). The Genedoc alignment editor was used (http://www.psc.edu/biomed/genedoc/). Secondary structure predictions were done at http://bioinf.cs.ucl.ac.uk/psipred/ (16), and protein modeling was done at the website of Swiss-Model (http://www.expasy.org/swissmod/SWISS-MODEL.html) in the alignment interface mode (25).
Expression plasmid construction.
An intermediate construct, pNBVSpmo9, was digested with BamHI, and the resulting 4.8-kb fragment containing the pmo cluster was gel purified. After ligation to BamHI-cut pUS1872 and transformation in E. coli DH5
, two types of clone were isolated, depending on the orientation of the insert relative to the hsp60 promoter. pUSpmo11 contained the pmo cluster downstream of hsp60p, and pUSpmo5 contained the pmo cluster upstream of hsp60p.
To obtain pNBVpmo11 and pNBVpmo15, we cut pUSpmo11 and pUSpmo5, respectively, with BglII, treated them with T4 DNA polymerase, and then cut them with HindIII before agarose gel purification. The purified 5-kb DNA fragment (containing the hsp60p and pmo genes) was ligated to pNBV1 after cutting with ClaI, filling in with T4 DNA polymerase, and cutting with HindIII. The selection of DH5
transformants on Luria broth plus hygromycin (0.2 mg/ml) plates yielded pNBVpmo11 and pNBVpmo15, respectively (Fig. 1).
![]() View larger version (28K): [in a new window] |
FIG. 1. Genetic map and features of the alkene monooxygenase genes of Mycobacterium sp. strain M156. (A) pPMOA903, pPMOAC85, and pPMOK201 are constructs created by cloning of the respective SmaI, EcoRI, and PstI fragments, as indicated by the horizontal bars. The E. coli-mycobacterium shuttle constructs for homologous expression are also shown as pNBVpmo11 and pNBVpmo15, with the location of the hsp60 promoter (gray triangles) indicated. Propene oxide formation activities obtained from whole-cell assays are indicated on the right. (B) DNA region showing the end of pmoA overlapping with the start of pmoB. The stop codon and start codon are underlined. (C) Region at the end of pmoC displaying the slippage codons (in italics), the overlapping start and stop codons (underlined), and the plausible stem-loop (inverted arrows).
|
The reaction mixtures were placed on ice for 2 min, and then the parental, supercoiled double-stranded DNA was digested with 0.5 µl of DpnI at 37°C for 1 h before being transformed into competent E. coli XL1 Blue cells. Mutations were verified by DNA sequencing.
Recombinant M. smegmatis induction experiments.
For expression, the 2.1-kb NdeI-NheI fragment of wild-type pmo in pNBVpmo15 was replaced with the appropriate mutant version, followed by electroporation into M. smegmatis mc2155 (12). The resulting transformants were used as templates for colony PCRs with Accuzyme DNA polymerase (BioLine) and the primers PM3025 (5'-GTT GTC ACC GTT GCG CAC-3') and SEA3 (5'-GCA AAT CAA CGG ATC GTC-3'). The cycling parameters were an initial melting step at 94°C for 5 min followed by 30 cycles of melting at 94°C for 30 s, annealing at 55°C for 1 min, and extension at 72°C for 2 min. A 1-kb DNA fragment confirmed the presence of the pmo insert, and sequencing of the PCR product verified the presence of the appropriate mutation(s). Recombinant strains of M. smegmatis mc2155 were grown aerobically at 28°C in 500 ml of NMS medium (32) containing 0.4% (wt/vol) sodium succinate, Tween 20 (20% [vol/vol]), and either 0.05 mg of hygromycin/ml or 0.025 mg of kanamycin/ml in a 2.5-liter flask until an optical density at 600 nm (OD600) of 0.1 was reached. One milliliter of acidified FeSO4 solution (1.12% [wt/vol]) was added to the culture, which was then incubated as described above for a further 5 h (final OD600,
0.5). The cells were harvested by centrifugation at 5,000 x g at 4°C for 20 min and washed sequentially with 20 ml of NMS medium and then 40 ml of ice-cold MOPS (morpholinepropanesulfonic acid) buffer (pH 7.5). The resulting cell pellet was resuspended in sufficient MOPS buffer (pH 7.5) to give a final OD600 of 20.
Monooxygenase assay. (i) Propene biotransformation.
Cell suspensions (1 ml) were assayed for propene oxidation at 30°C as previously described (33).
(ii) Styrene biotransformation assays.
For styrene biotransformation assays, the assay for propene oxidation was followed except that 10 µl of 1 M styrene in acetone was added instead of propene. After 90 min, the reaction was quenched on ice, the cells were pelleted by centrifugation (15,000 x g, 10 min), and the supernatant was extracted with 200 µl of ethyl acetate. The organic layer was dried over anhydrous sodium sulfate prior to analysis. The initial quantification of styrene oxide was done by gas chromatography-flame ionization detection (GC-FID) as described above on a 1M Tenax TA column at 200°C. For chiral separation, a 50-m by 0.25-mm FS-Lipodex C chiral capillary column (Macherey-Nagel, Duren, Switzerland), maintained isothermally at 70°C, was used, with the injector and detector maintained at 200°C and a split ratio of 1:50. Under these conditions, R- and S-styrene oxide enantiomers eluted at 44.9 and 47.1 min, respectively.
Nucleotide sequence accession number.
The sequences described in this report have been deposited with GenBank at NCBI (http://www.ncbi.nlm.nih.gov/) and are available under accession number AY455999.
|
|
|---|
Sequence analysis of the pmoABCD gene cluster.
Four potential genes were assigned by taking into account the higher G+C contents in their coding regions (2) and also by analogy with the translated sequence of R. corallinus AMO. The start codon of pmoA is GTG instead of the ATG for R. corallinus; it is preceded by a possible ribosomal binding site (AGGA) eight nucleotides upstream. As in the case of R. corallinus and Pseudonocardia K1 (30), the first nucleotide of the initiation codon for the coupling protein immediately precedes the stop codon of the oxygenase small subunit (Fig. 1B). No obvious ribosome binding site was found for pmoB (except an AGGGG sequence nine nucleotides upstream). An intergenic distance of 31 nucleotides separates the stop codon of pmoB and the start codon of pmoC, which is significantly more than the 11 nucleotides in the case of R. corallinus. A possible ribosome binding site (GAAAGG) is present 11 bp before pmoC. The start codon of pmoD and the stop codon of pmoC overlap by 1 bp (TGATG) (Fig. 1B), and as in the case of pmoB, no ribosome binding site was evident for pmoD. However, potential slippage codons are present 15 bp upstream of the pmoD start codon (AAAAACCCC) (Fig. 1B) and a possible 23-bp stem-loop is present 11 bp after the initiation codon of pmoD (39.5 kcal/mol) (Fig. 1), both of which may contribute to ribosomal frameshifting (7) and therefore enable the translation of pmoD. The intergenic distance between pmoD and the next ORF is 180 bp.
The G+C content of the pmoABCD cluster is 64.0%, which is consistent with values described for other mycobacterial genes (3, 9), and its codon usage is typical of Mycobacterium spp. (data not shown). The G+C contents at silent third positions of sense codons for the pmoABCD genes are 84.1, 80.4, 88.2, and 82.7%, respectively, which were slightly closer to that of M. smegmatis than to that of Mycobacterium tuberculosis (particularly for Asn, His, Ile, Lys, Phe, and Tyr) when compared by use of a graphical codon usage analyzer (http://gcua.schoedl.de/).
Modeling of PmoC.
Similarity searches showed that PmoA, -B, -C, and -D are most similar to their counterparts from AMO of R. corallinus (23) and from ETN of Mycobacterium rhodesiae (4). However, significantly, PmoA and PmoC have 25 and 33% sequence identities with the ß and
subunits of sMMO, respectively, which are sufficient to allow realistic modeling of the available structures for this enzyme. The crystal structures of the hexameric oxygenase components of sMMO from Methylococcus capsulatus and Methylosinus trichosporium have shown that the catalytic di-iron center is located at the base of a hydrophobic cavity formed by residues from four helices in the
subunit (5, 21, 22). The six iron binding residues, Glu114 (helix B), Glu144, His147 (helix C), Glu209 (helix E), Glu243, and His 246 (helix F), together with the helical structure and several other residues, are completely conserved in many monooxygenase homologues, including PmoC and AmoC (Fig. 2), and PmoC models closely to the sMMO
subunit in this region. Furthermore, electron paramagnetic resonance studies of the R. corallinus oxygenase indicated the existence of a bridged binuclear iron center (8). Given the extent of amino acid sequence identity between AmoC and PmoC and the conservation of key residues involved in iron binding, we envisage that the PMO cluster also contains a binuclear nonheme iron center.
![]() View larger version (73K): [in a new window] |
FIG. 2. Active-site residues of Mycobacterium sp. strain M156 ß subunit (PmoC) aligned with homologs. The sequences aligned with PmoC are as follows: MEMA_METTR from Methylosinus trichosporium OB3b (GenBank accession no. P27353); MEMA_METCA from Methylococcus capsulatus Bath (GenBank accession no. P22869); AmoC from Rhodococcus corallinus B-276 (GenBank accession no. BAA07114); ETNC from M. rhodesiae JS60 (GenBank accession no. AAO48576); the rsph3375 protein, a Rhodococcus sphaeroides hypothetical oxygenase (GenBank accession no. ZP_00007442); the blr3677 protein, a Bradyrhizobium japonicum hypothetical oxygenase (GenBank accession no. BAC48942); PRMA from Gordonia sp. strain TY-5 (GenBank accession no. BAD03956); THMA from Pseudonocardia K1 (GenBank accession no. CAC10506); and TMOA_PSEME from Pseudomonas mendocina (GenBank accession no. Q00456). The alignment shows only some of the amino acids within the active site (Leu110 to Ile239), as previously defined (5, 21, 22). Ligands of the binuclear iron center are joined with black lines. The residues forming the active site are highlighted with white diamonds ( ).The positions of Ala 94 and Val 188 in PmoC, which were subjected to mutagenesis in this study, are indicated with black triangles. Residues that are known or predicted to form helices (H) are indicated. Secondary structure information was taken from M. capsulatus Bath (pdb code 1mty chain D) and Methylosinus trichosporium (pdb code 1mhy chain D). PmoCpred is the predicted secondary structure of PmoC, as described in Materials and Methods.
|
Unsurprisingly, given the high instability of the constructs, no propene oxidation activity was detected with pNBVpmo11 transformants. However, a low activity was seen with pNBVpmo15, suggesting that expression occurred from a weak, uncharacterized promoter. These experiments were done with cells grown on 7H9 medium, which is a relatively rich medium. In a minimal salts medium with supplements of iron, a much higher constitutive activity, 16.3 nmol/min/mg of protein (Fig. 1), was obtained. Cell extracts of active recombinant cells did not show any overexpressed polypeptides by SDS-polyacrylamide gel electrophoresis, unlike the situation with the wild type. This suggests that the low level of activity was the result of poor expression from an uncharacterized promoter situated in the pAL5000 component. Only
708 bp separates the end of pAL5000 and the initiation codon of pmoA in pNBVpmo15, and the restriction map of pNBV1 indicates that the short rap gene (29) lies immediately upstream of pmoABCD.
Site-directed mutagenesis of PmoC and stereoselectivity of PmoC isoforms.
Two glycine residues (G113 and G208) lie adjacent to the nonbridging glutamate residues that coordinate the iron center in sMMO (5, 21, 22) The equivalent residues in other nonheme iron monooxygenase enzymes are usually aliphatic, but the length (and hence bulk) of the side chain varies. It seems plausible that the increasing steric bulk of these residues may be at least partly responsible for the increasing stereoselectivity of epoxidation observed upon going from sMMO via PMO and AMO to XAMO. Therefore, we mutated A94 and V188 (the equivalent residues to G113 and G208) in the PMO
subunit to increase and decrease the steric bulk and then investigated the resultant effects on the stereoselectivity of styrene epoxidation reactions.
The A94G, A94V, V188A, and V188L mutants were constructed by site-directed mutagenesis and introduced into the same expression system, as described above. The activity of PMO in these mutant isoforms was verified under standard assay conditions, and all were found to possess propene oxidation activity at a level similar to that of the recombinant wild-type enzyme, demonstrating that A94 and V188 are not essential for catalysis. Furthermore, propene oxide was the only product obtained in these assays, indicating that there had been no loss of reaction selectivity. Additionally, whole cells of M. smegmatis mc2155 expressing the natural and mutant isoforms of pmoC were found to catalyze the oxidation of styrene to styrene oxide, again at similar levels and with styrene oxide as the only product. Whole cells of M. smegmatis mc2155 did not catalyze this reaction, nor did whole cells of M. smegmatis mc2155 transformed with a control plasmid (pNBV1).
Figure 3 shows the stereoselectivities of styrene epoxidation catalyzed by the natural isoform and the mutant isoforms of PmoC described in this work. The recombinant wild-type enzyme converted styrene to styrene oxide, producing mainly the (R)-enantiomer, with an enantiomeric excess of 55.4%. The epoxidation of styrene by the mutant isoforms also predominantly produced (R)-styrene oxide, except for that of the A94G mutant, which effectively produced racemic styrene oxide [enantiomeric excess of 1.2% for the (S)-enantiomer]. Although three of the four mutations resulted in lower degrees of stereoselectivity, the V188L isoform, in which the steric bulk of the side chain was increased, gave an improved enantiomeric excess of 61.8%.
![]() View larger version (19K): [in a new window] |
FIG. 3. Stereoselectivities of styrene epoxidation catalyzed by the natural isoform (WT) and mutant isoforms of PMO. The results are from capillary GC-FID analysis of the reaction products obtained from resting cell biotransformation assays. Each experiment was performed in triplicate, and the mean data are presented.
|
The stereoselectivities of styrene oxidation observed for the A94G and A94V isoforms are less straightforward to explain. Although the introduction of a smaller residue at this position led to a virtually complete loss in the optical purity of the product compared to the natural isoform, the converse cannot be said to be true. The A94V isoform, in which valine was substituted for alanine, exhibited a lower stereoselectivity than the wild-type enzyme. As with V188, A94 is adjacent to a conserved glutamate residue (E95) that coordinates with a nonheme iron atom. Primary sequence alignments showed that many nonheme iron monooxygenases (including methane monooxygenase, which is not known to be stereoselective) have a glycine residue that aligns with A94 in PmoC, while the propane monooxygenase from Gordonia sp. strain TY-5 (13) and two hypothetical nonheme iron monooxygenases have a proline at this position (Fig. 2). Both glycine and proline are known to disrupt protein
-helical regions. Although the crystal structures of methane monooxygenase (5, 22) indicate that the equivalent glycine (G113) lies in the middle of an
-helix, this may reflect the fact that in the absence of substrates, the surrounding four-helix bundle provides the rigidity to counteract the disruptive effect of the glycine. However, during the catalytic cycle, expansion of the four-helix bundle might allow the glycine to act as a hinge point, generating some flexibility in helix B. The enzymes with a proline at this position presumably have a permanent bend in the equivalent helix. With the notable exception of a valine in XAMO (34), most of the other oxygenases have an alanine at this position, including all of the three-component alkene monooxygenases. This would serve to reduce the flexibility of the protein backbone, which might be the real reason for the difference at A94 and would explain the lack of correlation between a change in the volume of the side chain at this position and the stereoselectivity. The equivalent residue in T4MO (G103) has already been targeted by site-directed mutagenesis, and it was reported that introducing a leucine residue in place of glycine at this position in T4MO significantly alters the regiospecificity of aromatic hydroxylation compared to the natural isoform of the enzyme (17). This could easily be the result of a change in the backbone structure resulting from a local increase in helix stability rather than a direct effect arising from the increased bulk of the amino acid side chain.
S.A. was supported by a BBSRC Committee Studentship. C.K.C.K.C. was funded by BBSRC grant 28/T02831.
Present address: Haematology Department, Imperial College Hammersmith Campus, London W12 0NN, United Kingdom. ![]()
Present address: Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»